Search -

Displaying 521 - 540 of 671

Sort: Relevancy | Date

Presentation TCT 2012

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Roxana Mehran

October 25, 2012

Presentation TCT 2012

Part 2: Antiplatelet Agents

Presenter: Robert Harrington

October 25, 2012

Presentation TCT 2012

Part 1: Oral Anticoagulants

Presenter: Christopher Granger

October 25, 2012

Presentation TCT 2012

Debate: Clopidogrel is Enough and Still Plays a Role for Most!

Presenter: Michael Love

October 25, 2012

Presentation TCT 2012

ADAPT-DES One Year: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes

Presenter: Gregg Stone

October 25, 2012

Presentation TCT 2012

Ticagrelor Update: PLATO: Recent Analyses

Presenter: Robert Harrington

October 24, 2012

Presentation TCT 2012

Rivaroxaban Update: ATLAS-ACS-2 TIMI-51: Recent Analyses and FDA Redux

Presenter: C. Michael Gibson

October 24, 2012

Presentation TCT 2012

Prasugrel Update: TRILOGY

Presenter: E. Magnus Ohman

October 24, 2012

Presentation TCT 2012

Prasugrel Is the Gold Standard!

Presenter: Matthew Price

October 24, 2012

Presentation TCT 2012

GP IIb/IIIa Inhibition: New Studies, New Insights

Presenter: David Moliterno

October 24, 2012

Presentation TCT 2012

Factor IXa Inhibition (Aptamer) Update

Presenter: Roxana Mehran

October 24, 2012

Presentation TCT 2012

Clopidogrel Is Still the Choice for Most!

Presenter: Shamir Mehta

October 24, 2012

Presentation TCT 2012

"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting...

Presenter: Hyeon-Cheol Gwon

October 24, 2012

Presentation TCT 2012

"Short- Versus Long-term Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Randomized Multicentre Trial." Circulation. 2012;125:2015-2026.

Presenter: Marco Valgimigli

October 24, 2012

Presentation TCT 2012

Ticagrelor Is the Right Choice: More Potent, Better Data!

Presenter: Dimitrios Alexopoulos

October 24, 2012

Presentation TCT 2012

The Longer the Better Is Still the Way to Go, at Least for Now!

Presenter: Laura Mauri

October 24, 2012

Presentation TCT 2012

Medical Therapy During Interhospital Transport: Fibrinolytic and/or Anticoagulant?

Presenter: Frans Van de Werf

October 24, 2012

Presentation TCT 2012

Longer Is Better Is Old School Thinking!

Presenter: Marco Valgimigli

October 24, 2012

Presentation TCT 2012

Cangrelor: CHAMPION PHOENIX Update

Presenter: Harvey White

October 24, 2012

Presentation TCT 2012

Bivalirudin: New Analyses, New Studies

Presenter: Gregg Stone

October 24, 2012

Advertisement

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Part 2: Antiplatelet Agents

Part 1: Oral Anticoagulants

Debate: Clopidogrel is Enough and Still Plays a Role for Most!

ADAPT-DES One Year: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes

Ticagrelor Update: PLATO: Recent Analyses

Rivaroxaban Update: ATLAS-ACS-2 TIMI-51: Recent Analyses and FDA Redux

Prasugrel Update: TRILOGY

Prasugrel Is the Gold Standard!

GP IIb/IIIa Inhibition: New Studies, New Insights

Factor IXa Inhibition (Aptamer) Update

Clopidogrel Is Still the Choice for Most!

"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting...

"Short- Versus Long-term Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Randomized Multicentre Trial." Circulation. 2012;125:2015-2026.

Ticagrelor Is the Right Choice: More Potent, Better Data!

The Longer the Better Is Still the Way to Go, at Least for Now!

Medical Therapy During Interhospital Transport: Fibrinolytic and/or Anticoagulant?

Longer Is Better Is Old School Thinking!

Cangrelor: CHAMPION PHOENIX Update

Bivalirudin: New Analyses, New Studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content